AJMC August 2, 2024
“We are at an inflection point regarding treatment of obesity,” said Robert Kushner, MD, MS, Northwestern University Feinberg School of Medicine.
In January 2023, Robert Kushner, MD, MS, professor of medicine and medical education at Northwestern University Feinberg School of Medicine, and Ania Jastreboff, MD, PhD, professor of medicine and pediatrics at Yale School of Medicine, published a review of glucagon-like peptide 1 (GLP-1) receptor agonists and the future of nutrient-stimulated hormone-based antiobesity therapeutics.
This year, at the American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, Kushner presented on the “new era” of obesity management, emphasizing the therapeutic targeting of the gut-brain axis with GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)–mimicking hormones. According to Kushner, these advanced treatments...
Today's Sponsors
Today's Sponsor